Technology Articles

Portable Iron Market Growth Outlook Showing 4.3% CAGR Through 2034

The global portable iron market, valued at USD 1.85 billion in 2025, is projected to reach USD 2.75 billion by 2034 at a CAGR of 4.3%. Growth is driven by rising travel, urbanization, and demand for compact garment care solutions, supported by innovations in steam functionality, smart features, and energy-efficient designs.

Read More

Pharmacovigilance (PV) Outsourcing Market Expected to Witness 9.3% CAGR During 2026–2034 with Emerging Trends

 According to a new report from Intel Market Research, the global Pharmacovigilance (PV) Outsourcing market was valued at USD 7.2 billion in 2025 and is projected to reach USD 14.5 billion by 2034, growing at a CAGR of 9.3% during the forecast period (2026–2034). This expansion is fueled by rising drug development pipelines, the adoption of AI-powered safety analytics, and increasing regulatory complexity in global drug safety monitoring.

Read More

Isoproterenol Market Size to Grow at 4.7% CAGR Between 2026–2034 Amid Innovation Surge

 According to a new report from Intel Market Research, the global Isoproterenol market was valued at USD 320 million in 2024 and is projected to reach USD 520 million by 2034, growing at a CAGR of 4.7% during the forecast period (2025-2034). This steady growth reflects increasing demand for emergency cardiac care medications amid rising cardiovascular disease prevalence worldwide.

Read More

Entereg (alvimopan) Market to Register 4.2% CAGR Over the Forecast Period 2026–2034

 According to a new report from Intel Market Research, the global Entereg (alvimopan) market was valued at USD 8.3 million in 2025 and is projected to reach USD 12.1 million by 2034, growing at a CAGR of 4.2% during the forecast period (2026-2034). This growth is driven by increasing surgical volumes and the adoption of enhanced recovery after surgery (ERAS) protocols worldwide.

Read More

Biologic Medications for Psoriasis Market Expanding at 7.8% CAGR from 2026–2034 with Strong Industry Adoption

 According to a new report from Intel Market Research, the global biologic medications for psoriasis market was valued at USD 14.5 billion in 2025 and is projected to reach USD 28.7 billion by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is fueled by increasing psoriasis prevalence, superior efficacy of biologics over conventional treatments, and significant advancements in biotechnology.

Read More